This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Marticorena-Alvarez P, Chaparro M, Perez-Casas A, Muriel-Herrero A, Gisbert JP.Probable diffuse retinopathy caused by adalimumab in a patient with Crohn's disease. Journal of Crohn's and Colitis 6: 950-953, No. 9, Oct 2012. Available from: URL: http://dx.doi.org/10.1016/j.crohns.2012.03.015 - Spain
Additional information
Key words
adverse reactions; drug-induced; Adalimumab; Retinal-disorders
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
Rights and permissions
About this article
Cite this article
Adalimumab. React. Wkly. 1426, 6 (2012). https://doi.org/10.2165/00128415-201214260-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214260-00019